Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting

OBJECTIVES: A growing body of evidence supports the effectiveness of injectable diacetylmorphine (i.e., heroin) for individuals with treatment-refractory opioid use disorder. Despite this evidence, and the increasing toll of opioid-associated morbidity and mortality, it remains controversial in some...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimas, Jan, Dong, Huiru, Fairbairn, Nadia, Socías, Eugenia, Barrios, Rolando, Wood, Evan, Kerr, Thomas, Montaner, Julio, Milloy, M.-J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812056/
https://www.ncbi.nlm.nih.gov/pubmed/29409539
http://dx.doi.org/10.1186/s13722-017-0104-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812056/
https://www.ncbi.nlm.nih.gov/pubmed/29409539
http://dx.doi.org/10.1186/s13722-017-0104-y

Ejemplares similares